Rend Al-Mondhiry Joins Faculty of ACI’s 12th Annual Legal, Regulatory and Compliance Forum on Dietary Supplements
Rend Al-Mondhiry will serve on a panel at ACI’s 12th Annual Forum on Dietary Supplements in New York City, June 25 -26. In a session titled “FDA Activity Round-Up and Industry Discussion: Forecasts for the Future of NDIs, Healthy Claims, IND Requirements and More,” Rend and co-panelist Jena Rostorfer, Director, US/Canada Regulatory Affairs, Abbott, will cover crucial lessons and takeaways from the latest trends in FDA enforcement, examine the status of “healthy” nutrient claims, and provide a status update on FDA’s proposed amendments to regulations on Investigational New Drug applications.
For complete event details, click here.
